Literature DB >> 18755695

Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43.

Giuseppe Celenza1, Carla Luzi, Massimiliano Aschi, Bernardetta Segatore, Domenico Setacci, Cristina Pellegrini, Chiara Forcella, Gianfranco Amicosante, Mariagrazia Perilli.   

Abstract

OBJECTIVES: The aim of this article is biochemical and kinetic characterization of CTX-M-43, a natural Asp-240-->Gly mutant of CTX-M-44 (ex Toho-1), from a clinical isolate of Acinetobacter baumannii isolated in a Bolivian hospital.
METHODS: Steady-state kinetic parameters (K(m) and k(cat)) were determined for a large pattern of substrates. Analysis of inactivators and transient inactivators was performed to determine the efficiency of acylation (k(+2)/K) and the deacylation constant (k(+3)). Molecular modelling of Michaelis complex of ceftazidime, cefotaxime and ceftibuten, obtained from molecular mechanics calculations, was carried out.
RESULTS: CTX-M-43 showed a general increase in affinity towards all cephalosporins tested, with respect to CTX-M-44. Carbapenems acted as inactivators with a good acylation efficiency for meropenem and ertapenem and significant deacylation constant for imipenem. MICs of imipenem obtained at a higher bacterial inoculum of recombinant Escherichia coli were increased.
CONCLUSIONS: Kinetic data and molecular modelling of Michaelis complex confirmed that Asp-240-->Gly allows a better accommodation of the bulky C7beta aminothiazol-oxyimino substituent, resulting in a general increase in the enzyme affinity towards oxyimino cephalosporins. The ascertained potentialities of CTX-M-type enzymes, supported by the kinetic data and the behaviour of the recombinant E. coli at different bacterial inocula towards carbapenems, make a possible evolution of those enzymes towards a carbapenemase activity plausible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755695     DOI: 10.1093/jac/dkn339

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  Molecular and biochemical characterization of CTX-M-131, a natural Asp240Gly variant derived from CTX-M-2, produced by a Providencia rettgeri clinical strain in São Paulo, Brazil.

Authors:  Milena Dropa; Barbara Ghiglione; Maria Helena Matté; Livia Carminato Balsalobre; Nilton Lincopan; Glavur Rogério Matté; Gabriel Gutkind; Pablo Power
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

3.  Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.

Authors:  Meha P Patel; Bartlomiej G Fryszczyn; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

4.  Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.

Authors:  Benoît Doublet; Sophie A Granier; Frédéric Robin; Richard Bonnet; Laëtitia Fabre; Anne Brisabois; Axel Cloeckaert; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

5.  Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Magdalena A Taracila; Marisa L Winkler; Julian A Gatta; Drew A Rholl; Herbert P Schweizer; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

6.  Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.

Authors:  Mohammad Faheem; Md Tabish Rehman; Mohd Danishuddin; Asad U Khan
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

7.  Molden 2.0: quantum chemistry meets proteins.

Authors:  Gijs Schaftenaar; Elias Vlieg; Gert Vriend
Journal:  J Comput Aided Mol Des       Date:  2017-07-27       Impact factor: 3.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.